Radiotherapy has an important role to play in the fight against cancer. Around 50% of patients cured of cancer received radiotherapy as part of their treatment.
Our Advanced Radiotherapy research will embrace technological advances and develop biomarkers to predict the effectiveness of different types of radiation and drug-radiation combinations, as well as helping to minimise the risk of long-term side effects.
We have world-leading clinical and experimental radiation facilities, including the Dalton Institute. Our radiotherapy facility is already the largest in Europe with 8,500 patients treated and 120,000 radiation fractions delivered annually.
Cancer patients in some other countries have access to high energy protons, but the first UK NHS Proton Therapy Centre will open in Manchester in 2018 to treat around 750 of the most complicated cancer patients each year.
Manchester will be the only UK site with three state-of-the-art techniques: Stereotactic Ablative Radiotherapy, which is operational now, a Magnetic Resonance Imaging scanner combined with a radiation machine (MR-linac) and high energy Proton Therapy.